Agency for Healthcare Research and Quality (AHRQ); 2026.
We selected randomized controlled trials and comparative nonrandomized studies that enrolled adult participants with Down syndrome to evaluate benefits and harms of screening, diagnostic, or treatment interventions. No studies addressing screening interventions were identified. We identified only a limited number of treatment interventions. Some improvements were observed for dementia, depression, sleep apnea, and mobility.
Freely available online